Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04680793
Other study ID # 2019-A02154-53
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 22, 2020
Est. completion date April 13, 2022

Study information

Verified date July 2022
Source Clinique de la Mitterie
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The management of patients with Ehlers-Danlos syndrome (EDS) is still underdeveloped in healthcare institutions in France. Although multidisciplinary management through exercise rehabilitation has demonstrated its benefits in many chronic pathologies, it has not been evaluated for EDS. As a result, to date there is no evidence of its effectiveness in patients with EDS. The objective of this study is therefore to objectively evaluate the effectiveness of such a treatment on the different dimensions of these patients' health.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date April 13, 2022
Est. primary completion date April 13, 2022
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - EDS diagnosis. - Inclusion in the rehabilitation program. Exclusion Criteria: - Absolute and relative cardio-vascular contraindications to rehabilitation. - Other contraindications to exercise. - Psychological contraindication (Beck questionnaire score = 20)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Rehabilitation
The program takes place over a total period of 9 weeks: for 4 weeks they will be cared for two days a week, then after a week's break, for 4 weeks they will be cared for three days a week for a total of approximately 80 hours of care. The program is multidisciplinary and includes: balneotherapy, ergometry, occupational therapy, gymnastics, physiotherapy, walking, sophrology, yoga as well as different workshops for the therapeutic education of the patient led by several professionals (dieticians, physiotherapists, doctors, psychologists).

Locations

Country Name City State
France Clinique de la Mitterie Lomme

Sponsors (1)

Lead Sponsor Collaborator
Hakimi Adrien

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Distance covered in the 6-minute walk test 9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Secondary Other data from the 6-minute walk test 9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Secondary Time of an endurance test on a cyclo-ergometer Baseline ; 9 weeks
Secondary Area swept by the gravity center during a balance test on a posturological platform Four balance tests : bipodal with eyes open, bipodal with eyes closed and unipodal with eyes open on the two sides 9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Secondary Tampa scale for kinesiophobia (questionnaire) 9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Secondary Brief pain inventory (questionnaire) 9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Secondary Nijmegen questionnaire 9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Secondary Multidimensional fatigue inventory (questionnaire) 9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Secondary Medical outcome study short form 36 (questionnaire) 9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
Secondary Hospital anxiety and depression scale (questionnaire) 9 weeks before baseline ; Baseline ; 9 weeks ; 15 weeks ; 8 months
See also
  Status Clinical Trial Phase
Completed NCT04437589 - Opioid-Free Anesthesia for Patients With Joint Hypermobility Syndrome Undergoing Craneo-Cervical Fixation: A Case-series
Not yet recruiting NCT05279937 - The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients Phase 3
Enrolling by invitation NCT05429996 - Ultrastructural Collagen Markers in Ehlers Danlos Syndromes
Not yet recruiting NCT03575182 - Gait Retraining in Patients With Joint Hypermobility Syndrome/Hypermobile Ehlers Danlos Syndrome N/A
Recruiting NCT05561270 - Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome N/A
Completed NCT01322165 - National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions N/A
Active, not recruiting NCT05603741 - Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers Phase 4
Enrolling by invitation NCT05434728 - Characterization of Bleeding Disorders in EDS
Completed NCT01356134 - Vascular Fundus Changes in Patients With High Probability of Chronic Cerebrospinal Venous Insufficiency (CCSVI) N/A
Completed NCT05137379 - Evaluation of a Cohort of Patients With Ehlers-Danlos Syndrome Treated With Orthopedic Surgery (SED-eval)
Recruiting NCT02050113 - Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices N/A
Recruiting NCT04890431 - Impact of Oxygen Therapy on Fatigue in Patients With Hypermobile-type Ehlers-Danlos Syndrome Phase 4
Completed NCT03602482 - Standing Cognition and Co-morbidities of POTS Evaluation N/A
Recruiting NCT04133272 - Registry of Ehlers-Danlos Syndrome
Completed NCT05516043 - Safety and Performance of POLYTHESE® Vascular Prosthesis
Recruiting NCT06105541 - Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation N/A
Enrolling by invitation NCT04036305 - Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
Recruiting NCT03596437 - Study of Arterial Properties by Ultra-high Frequency Ultrasound in Fibromuscular Dysplasia and Vascular Ehlers-Danlos Syndrome N/A
Completed NCT00270686 - Studies of Heritable Disorders of Connective Tissue
Completed NCT00001966 - Mind-Body Therapy for Pain in Ehlers-Danlos Syndrome Phase 2